🇺🇸 FDA
Patent

US 12324828

Conjugates of a factor VIII moiety having an oxime-containing linkage

granted A61KA61K38/37A61K47/54

Quick answer

US patent 12324828 (Conjugates of a factor VIII moiety having an oxime-containing linkage) held by Nektar Therapeutics expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/37, A61K47/54, A61K47/60, A61P